Aspirin, acetaminophen and proton transport through phospholipid bilayers and mitochondrial membranes - PubMed (original) (raw)

. 1992 Sep 8;114(1-2):3-8.

doi: 10.1007/BF00240290.

Affiliations

• PMID: 1334228
• DOI: 10.1007/BF00240290

Aspirin, acetaminophen and proton transport through phospholipid bilayers and mitochondrial membranes

J Gutknecht. Mol Cell Biochem. 1992.

Abstract

Mechanisms of proton transport were investigated in planar phospholipid bilayer membranes exposed to aspirin (acetylsalicylic acid), acetaminophen (4-acetamidophenol), benzoic acid and three aspirin metabolites (salicylic acid, gentisic acid and salicyluric acid). The objectives were to characterize the conductances and permeabilities of these weak acids in lipid bilayer membranes and then predict their effects on mitochondrial membranes. Of the compounds tested only aspirin, benzoate and salicylate caused significant increases in membrane conductance. The conductance was due mainly to proton current at low pH and to weak acid anion current at neutral pH. Analysis of the concentration and pH dependence suggests that these weak acids act as HA-2-type proton carriers when pH approximately pK and as lipid soluble anions at neutral pH. Salicylate is much more potent than aspirin and benzoate because salicylate contains an internal hydrogen bond which delocalizes the negative charge and increases the permeability of the anion. Model calculations for mitochondria suggest that salicylate causes net H+ uptake by a cyclic process of HA influx and A- efflux. This model can explain the salicylate-induced uncoupling and swelling observed in isolated mitochondria. Since ingested aspirin breaks down rapidly to form salicylate, these results may clarify the mechanisms of aspirin toxicity in humans. The results may also help to explain why the ingestion of aspirin but not acetaminophen is associated with Reye's syndrome, a disease characterized by impaired energy metabolism and mitochondrial swelling.

PubMed Disclaimer

Similar articles

• Reye's syndrome: salicylates and mitochondrial functions.
  Martens ME, Lee CP. Martens ME, et al. Biochem Pharmacol. 1984 Sep 15;33(18):2869-76. doi: 10.1016/0006-2952(84)90209-0. Biochem Pharmacol. 1984. PMID: 6477646
• Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome.
  Trost LC, Lemasters JJ. Trost LC, et al. Toxicol Appl Pharmacol. 1997 Dec;147(2):431-41. doi: 10.1006/taap.1997.8313. Toxicol Appl Pharmacol. 1997. PMID: 9439738
• Proton conductance through phospholipid bilayers: water wires or weak acids?
  Gutknecht J. Gutknecht J. J Bioenerg Biomembr. 1987 Oct;19(5):427-42. doi: 10.1007/BF00770028. J Bioenerg Biomembr. 1987. PMID: 2826410 Review.
• Proton permeation of lipid bilayers.
  Deamer DW. Deamer DW. J Bioenerg Biomembr. 1987 Oct;19(5):457-79. doi: 10.1007/BF00770030. J Bioenerg Biomembr. 1987. PMID: 2447068 Review.

Cited by

• PerMM: A Web Tool and Database for Analysis of Passive Membrane Permeability and Translocation Pathways of Bioactive Molecules.
  Lomize AL, Hage JM, Schnitzer K, Golobokov K, LaFaive MB, Forsyth AC, Pogozheva ID. Lomize AL, et al. J Chem Inf Model. 2019 Jul 22;59(7):3094-3099. doi: 10.1021/acs.jcim.9b00225. Epub 2019 Jul 1. J Chem Inf Model. 2019. PMID: 31259547 Free PMC article.
• Does transbilayer diffusion have a role in membrane transport of drugs?
  Balaz S. Balaz S. Drug Discov Today. 2012 Oct;17(19-20):1079-87. doi: 10.1016/j.drudis.2012.06.003. Epub 2012 Jun 15. Drug Discov Today. 2012. PMID: 22705388 Free PMC article. Review.
• Chloride channel function in the yeast TRK-potassium transporters.
  Kuroda T, Bihler H, Bashi E, Slayman CL, Rivetta A. Kuroda T, et al. J Membr Biol. 2004 Apr 1;198(3):177-92. doi: 10.1007/s00232-004-0671-1. J Membr Biol. 2004. PMID: 15216418
• Aspirin increases mitochondrial fatty acid oxidation.
  Uppala R, Dudiak B, Beck ME, Bharathi SS, Zhang Y, Stolz DB, Goetzman ES. Uppala R, et al. Biochem Biophys Res Commun. 2017 Jan 8;482(2):346-351. doi: 10.1016/j.bbrc.2016.11.066. Epub 2016 Nov 14. Biochem Biophys Res Commun. 2017. PMID: 27856258 Free PMC article.
• Inhibitors of signal peptide peptidase (SPP) affect HSV-1 infectivity in vitro and in vivo.
  Allen SJ, Mott KR, Ghiasi H. Allen SJ, et al. Exp Eye Res. 2014 Jun;123:8-15. doi: 10.1016/j.exer.2014.04.004. Epub 2014 Apr 24. Exp Eye Res. 2014. PMID: 24768597 Free PMC article.

References

1. 1. Nature. 1973 May 25;243(5404):234-6 - PubMed
2. 1. J Gen Physiol. 1976 Jun;67(6):749-71 - PubMed
3. 1. Arch Biochem Biophys. 1989 Sep;273(2):449-57 - PubMed
4. 1. J Pharmacol Exp Ther. 1956 May;117(1):39-51 - PubMed
5. 1. J Pharm Sci. 1969 Jan;58(1):102-5 - PubMed

Publication types

MeSH terms

Substances